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This article aimed to test the general hypothesis that guidelines create uniformity, or reduce variation, in
medical practice. Medical practice variation has policy interest and is one of the reasons for developing
guidelines. The development and implementation of guidelines was considered in the broader context of
processes of rationalization. We focused on the inﬂuence of voluntary guidelines developed by the
professional organization for family physicians in the Netherlands on variation in drug prescription.
Data were used from the First and Second Dutch National Survey of General Practice (DNSGP1 and
DNSGP2), collected in 1987 and 2001 respectively. DNSGP1 consisted of 103 practices and 161 GPs
serving 335.000 patients. DNSGP2 consisted of 104 practices and 195 GPs serving 390.000 patients. Two
groups of diagnoses were created, one containing all diagnoses for which guidelines were introduced
and one containing all other diagnoses. For both groups a measure of concentration, Herﬁndahl-
Hirschman Index (HHI), was used to represent variation. This measure of concentration was compared
between both groups using multilevel analysis.
Results showed that although there was an overall increase in variation (a signiﬁcantly lower HHI) in
prescription, the increase was less in the cases of diagnoses for which guidelines were introduced.
Guidelines, primarily, had an effect on variations in single-handed practices. The overall conclusion is
that the introduction of guidelines, although it probably tempered the increase in variation, did not
reduce variation.
 2009 Elsevier Ltd. All rights reserved.Introduction 1999). Variation in medical practice is not a bad thing by deﬁnition;In the classical conception of medicine as a profession, medical
practice is largely uniform through the shared body of (theoretical)
knowledge. Variation originates from the necessity to apply this
theoretical knowledge to individual patients. However, when
clinical variables and patient characteristics are taken into account,
there is variation left.Whatever the origin of this part of variation, it
is striking that this variation has been found to show clear patterns
by country, region, hospital and practice. Explanations for variation
are sought in differences in opinions or enthusiasm for certain
procedures between individual physicians, and in differences in
constraints and social inﬂuences for groups of physicians (Chassin,
1993; de Jong, 2008; Landon, Reschovsky, Reed, & Blumenthal,
2001; Wennberg & Gittelsohn, 1975; Westert & Groenewegen,x 1568, 3500 Utrecht, BN,
All rights reserved.without variation there probably will be no progress. However, it is
the downside of variation that attracts attention from third parties.
Evidence of variations inmedical practice suggests the possibility of
inappropriate servicing, wasting of resources and even actual harm
to patients (Evans, 1990). The existence of variation has policy
interest and is one of the reasons, besides rising health care costs,
for developing guidelines. The use of clinical guidelines that give
recommendations about appropriate health care is a way of
reducing variation and maintaining, or improving, the quality of
health care (Grilli, Magrini, Penna, Mura, & Liberati, 2000;
Hutchinson, McIntosh, Cox, & Gilbert, 2003; Langley, Faulkner, Ch.
Watkins, Gray, & Harvey, 1998; Lomas et al., 1989). Awide variety of
guidelines has been developed in the last decades for hospitals and
physicians (Grimshaw et al., 2004; Hibble, Kanka, Pencheon, &
Pooles, 1998). In this article guidelines for family physicians in the
Netherlands will be studied.
In The Netherlands guidelines are developed for family physi-
cians by the Dutch College of General Practitioners. The ﬁrst




























Fig. 1. Creating the guideline and the reference group.
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adherence to guidelines (e.g. Grol, 2001; Hermens, Hak, Hulscher,
Braspenning, & Grol, 2001; Schers, Braspenning, Drijver, Wensing,
& Grol, 2000; Tiemeier et al., 2002; Groenhof, Bettink, van Dijk, van
der Veen, & Meyboom-de Jong, 2006), the impact on variation
among physicians is hardly ever studied (e.g. Mourad et al., 2008;
Verstappen et al., 2003).
The development and implementation of clinical guidelines can
be seen in the light of broader processes of rationalization, which
occur everywhere in modern society. Processes of rationalization
lead to more uniformity; guidelines introduced and followed by
physicians create uniformity. Still, processes of rationalization do
not lead to more uniformity in all respects. Although guidelines
may specify for instance the therapeutic substances of drugs that
are preferred for certain conditions, many different brands of drugs,
containing the same therapeutic substances, can coexist.
This article focuses on the inﬂuence of guidelines on variation in
drug prescription. It will not look at the contents of the guidelines,
nor test whether guidelines are being followed, nor whether the
quality of medical treatment is increased by the introduction of
guidelines. It will test the general hypothesis that guidelines create
uniformity. The general question addressed is: Is variation reduced
after guidelines are introduced? In other words: Do guidelines indeed
create uniformity?
Background and hypotheses
To answer this question we will discuss rationalization in
medicine. Secondly, the subject of guidelines will be discussed.
Thirdly, more information about family physicians and guidelines
in the Netherlands will be given. Finally, hypotheses will be
formulated on when to expect a decrease in variation after guide-
lines are introduced. More speciﬁc expectations can then follow.
Rationalization in medicine
Worldwide, the profession of medicine is increasingly subject to
the inﬂuences of market competition, forcing it towards stan-
dardization (Hafferty & Light, 1995; Ritzer & Walczak, 1988). The
production and diffusion of medical knowledge and technology are
increasingly international. There is a change from professional
dominance to managerial market orientation (Scott, Ruef, Mendel,
& Caronna, 2000). The United States is in front but Europe is on its
heels with the introduction of guidelines, protocols, diagnostic
related groups or similar reimbursement systems that exert pres-
sure to make more efﬁcient use of health care resources. The
profession is changing from being led by social values whenmaking
rational choices, to being controlled by rules and regulations (Ritzer
& Walczak, 1988). The institutional changes in the health care
sector that lead to increased formal rationality are expected toreduce variation in medical practice as physicians are increasingly
operating in a predictable manner. Based on a literature review,
Groenewegen and Westert (2004) concluded that there is indeed
a downward trend in medical practice variation.
Guidelines can be developed by different stakeholders such as
insurance companies and organizations of medical professionals.
They are supposed to increase the quality of care, or reduce costs,
depending onwhich body is producing the guideline. The source of
the guidelines is important as this is related to their acceptance by
physicians. It determines too whether they are normative, meaning
that there are no formal sanctions when the guidelines are not
followed, or regulative, including formal sanctions (Onion & Wally
1995; Tunis et al., 1994). For instance insurance companies can
develop guidelines in order to reduce costs. This goal in itself limits
the acceptance amongst physicians. These guidelines, however,
may still be followed because insurance companies can exert
regulative pressure using formal sanctions such as through the
authorization and rules on reimbursement for hospitals, physicians
and patients.
In this article guidelines developed by the professional organi-
zation for family physicians in the Netherlands will be studied.
These guidelines are normative, or voluntary rules, thus in essence
it is up to the individual physician whether they are followed.
The Netherlands
The role of family physicians in the Netherlands is described in
Box 1. The Netherlands are a precursor in the development of
clinical guidelines compared to other European countries. Guide-
lines are developed by the Dutch College of General Practitioners
(NHG), they have developed and published guidelines since 1989.
The guidelines were developed in order to improve the quality of
family physicians’ practice and can be used to support family
physicians in their daily practice, protect them from mistakes and
legitimize medical behavior. The guidelines relate to diagnostics,
treatment, referral, and prescribing. The NHG aims to achieve
evidence-based practical guidelines that are widely accepted. In
order to increase acceptance, the target group is involved in their
development (see Box 2). The idea is that guidelines are more
readily accepted and acted upon if made and implemented by the
profession itself (Brindis & Sennett, 2003; Francke, Smit, de Veer, &
Mistiaen, 2008; Grol, 2001).
Why and when would variation be reduced by the introduction of
guidelines?
Variation is expected to decrease when guidelines are followed.
It is not certain that people will follow guidelines, for being
different can be valued more than being similar (Brunsson &
Jacobsson, 2000). Being different is important when people need to
Box 2. Guideline development procedure.
The procedure to develop guidelines is as follows: the NHG
selects a topic for which a guideline should be formulated,
they mostly concern medical practice or organization;
a working group of family physicians develops the guideline
and this is sent to another 50 family physicians for comment.
After the guideline is revised, it is sent to an independent
scientific committee for authorization (Geijer et al., 1999).
Then, the guideline is published in the official journal of the
Dutch College of Family Physicians. Bothmembers and non-
members of the NHG react positively to the procedure and
consider the NHG capable of formulating widely accepted
guidelines to be used in family practice.
Box 1. Family physicians in the Netherlands.
Family physicians in the Netherlands have a gate-keeping
role. All publicly insured patients1 (all patients with an
income below 30.700 Euro for the year 2002, 60 percent of
the total population) are on the patient list of a family
physician or practice. Publicly insured patients have no
direct access to specialist care; they have to consult their
family physician first. Most of the privately insured patients
also visit their family physician before consulting a medical
specialist. Family physicians treat over 90 percent of all
complaints themselves (Cardol, de Bakker, & Westert, 2006;
Committee of the Health Council, 2004), family physicians
prescribe 75 percent of all drugs, and 65 percent of all
consultations end with a prescription (van Dijk, 2006).
Family physicians are working in single-handed practices
(42 percent), in duo practices (33 percent), or in group
practices (25 percent). (van den Berg, Kolthof, de Bakker &
van der Zee, 2004). The number of family physicians
working in single-handed practices is decreasing over time.
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many physicians it will be more important to have speciﬁc skills in
order to be able to offer different treatments from the others.
However, people will try not to be different if there is a degree of
uncertainty. In situations where one is unsure aboutwhat to do, it is
safer to demonstrate similar behavior to the others. By following
guidelines, it is easier to explainwhat has been done, and to achieve
acceptance. We will discuss two important mechanisms that
inﬂuence the reduction of variation when guidelines are intro-
duced: the uncertainty of the outcomes of, or the appropriateness
of, medical behavior and social integration in the profession. With
these mechanisms differences between physicians working in
single-handed practices and physicians working in group practices
can be expected.
Guidelines are developed to support family physicians in their
daily practice, and in this way ensure the quality of care (Grimshaw
& Russell, 1993; Grol, 2001; Lomas et al., 1989). Support is mostly
appreciated in cases where one is uncertain. In general, people are
most inﬂuenced by peers when there is a high degree of uncer-
tainty, and objective, unambiguous information is not available
(Bandura, 1986; Berkman, Glass, Brisette, & Seeman, 2000; Cialdini
& Trost, 1998). Hence, the ones most likely to use the guidelines to
reduce uncertainty, are those family physicians who do not have
colleagues around them to whom they might turn; physicians in
single-handed practices. Physicians surrounded by colleagues are
expected to show similar behavior to those colleagues (Berkman
et al., 2000; Eddy, 1984). This behavior could be based on profes-
sional guidelines, but also on local standards.
Family physicians in single-handed practice rely more on
patients for social approval, while family physicians sharing their
work environment with colleagues rely more on these role equiv-
alents for their social approval (Burkhardt, 1994; Freidson, 1970).
Family physicians working in single-handed practices may be less
likely to spend more time in activities other than those directly
related to patient care. Family physicians working in partnerships
increase social approval by engaging in professional activities. This
is related to following guidelines because the ones most likely to
work according to the guidelines are the ones most integrated in
the profession, those who are most likely to spend time keeping up1 In 2006 the difference between public and private insurance was abolished
with the introduction of a new health insurance system.with professional developments, and those who risk being sanc-
tioned by colleagues (Coleman, Katz, & Menzel, 1966). Family
physicians who do not share their work environment with
colleagues are less likely to be disciplined by colleagues because
their behavior is less visible to colleagues (Lulofs, 1981). The liter-
ature supports this. Family physicians spending more time in direct
patient care were more likely to deviate from indicators derived
from guidelines (Hutten, 1998).
Besides disciplining each other, other physicians are an impor-
tant source of information. Grol (2001) studied the successes and
failures of the implementation of guidelines and found as sources of
information: scientiﬁc journals; discussion of the guideline with
a local group of physicians; and contact with other physicians and
course attendance. Discussion and contact with colleagues goes
without saying for physicians sharing their work environment, but
it is less easy for family physicians working in single-handed
practices (O’Neill & Kuder, 2005).
One runs the risk of being criticized only when behavior is
visible. Although behavior is not always visible in a shared work
environment, it is more visible there than in a single-handed
practice, as colleagues in shared practices see each others’ patients.
To avoid the risk of being criticized they will imitate those close
colleagues with status and success, and behavior within a group
will show similarities (Burkhardt, 1994). Thus it is expected that
family physicians working in groups developed their own, local
standards, even in the absence of guidelines. Therefore, when
guidelines are introduced little change in variation between
physicians in group practices is expected. A change in behavior is,
however, perfectly conceivable when guidelines deviate from local
standards. So differences can be expected in the reduction of
variation between family physicians in single-handed and those in
group practices. In this article we will study the reduction in vari-
ation for drug prescription. It is hypothesized that:
1. Variation in drug prescription has decreased with the intro-
duction of guidelines.
2. Variation in drug prescription has decreased more for family
physicians working in single-handed practices than for family
physicians working in group practices.
Data and method
First and Second Dutch National Survey of General Practice
Datawere used from the First and Second Dutch National Survey
of General Practice (DNSGP1 and DNSGP2), collected in 1987 and
2001 respectively. In 1987 there were no guidelines, while in 2001
75 guidelines were available (http://www.nhg.artsennet.nl/
guidelines). Data were collected on contacts, patients, family
Table 2













ICPC-codes 77 57 77 57
Practices 102 102 69 69
FPs 160 160 108 108
FPs diagnoses 7858 5115 7093 4460
Table 1




Number of practices 103 104
Number of FPs 161 195
Number of patients 335.000 390.000
Registration period 3 months 1 year
Data collection On registration forms FP information systems
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and comparability we refer to Westert et al. (2005). A summary of
differences between both surveys can be found in Table 1. We will
elaborate on two differences between the surveys that inﬂuenced
the design of the analyses: the registration period and the method
of data collection.
From all family physicians participating in DNSGP2, data for one
year were retrieved from the electronic medical records. Family
physicians participating in DNSGP1 were divided into four groups.
Each recorded information on sheets during one of four consecutive
three month periods.
During DNSGP1 the data were collected on paper registration
forms, while the data for DNSGP2 were retrieved from Electronic
Medical Records (EMR), including diagnoses, prescription, and
referral. The problemof differences in data collection and registration
period between DNSGP1 and DNSGP2 was solved by comparing
differences within one study to differences within the other study.
Groups of diagnoses with and without guidelines
In order to make a comparison possible, we decided to examine
differences within studies between groups of diagnoses. For
DNSGP1 two groups were created, one containing all diagnoses for
which guidelines were about to appear, and one for which no
guidelines were developed until DNSGP2 (Fig. 1). For DNSGP2 we
also made two groups of diagnoses, one for which guidelines have
appeared and one for which there were no guidelines in 2001. So
the diagnoses in both studies were divided into two groups,
a guideline group and a reference group. The ﬁrst group was made
by selecting codes of the international classiﬁcation of primary care
(ICPC-codes) (Lamberts, Wood, & Hofmans-Okkes, 1993) related to
75 NHG guidelines (see Web Appendix 1). In the reference group
we have all ICPC-codes for which no guideline existed in 2001.
Exclusions
Practices were excluded from the analyses if the data recorded
were far from complete, for example if the period of recording data
was only a few weeks, or ICPC-codes were scarcely recorded. Cases
were excluded too for which no drugs could be identiﬁed, based on
the ATC-5 code (Anatomical Therapeutic Chemical, 1993). Diag-
noses that occurred less frequently, deﬁned as less than 100
patients per diagnosis per study, were excluded. Furthermore, in
DNSGP1 and DNSGP2 the same diagnoses were included.
In total 36 practices were thus excluded from the analyses, 32
due to incomplete recording. And 11735 cases were excluded
because no drugs could be identiﬁed based on the ATC-5 code. The
actual numbers of diagnoses in the study population, practices,
family physicians and ‘‘family physician diagnoses’’ in our study can
be found in Table 2. The diagnoses are counted per family physician,
‘‘family physician diagnoses’’ is the sum of all these different
diagnoses counted per physician. The exclusions did not have an
important negative effect on how representative this study was
(Table 3).Dependent variable
In this article variation will be represented as a concentration;
the higher the concentration the less variation in drug prescription.
As dependent variable a measure of concentrationwas used, the
Herﬁndahl-Hirschman Index (HHI) (Zwanziger, Melnick, &
Bamezai, 2000). This measure was based on the ‘‘market share’’ of
the drugs prescribed per diagnosis. The kind of drugs was identiﬁed
based on the ATC-5 code. The HHI was measured as
P
(a/b)2; where
a is the number of times a speciﬁc drug was prescribed per diag-
nosis, and b is the total number of times any drug is prescribed for
this diagnosis. This was measured for each drug prescribed per
diagnosis and these values were added for all drugs prescribed per
diagnosis. The range of this index goes from a low point of 1 divided
by the number of drugs prescribed per diagnosis to a maximum of
1. A low index means that all drugs are equally often prescribed
while 1 means that there is only one drug prescribed. The HHI was
multiplied by 100 for computational reasons. Example: if 5
different drugs are prescribed for one diagnoses and the ﬁrst is
prescribed 300 times, the second 100 times, the third 3 times, the
fourth 50 times and the ﬁfth 500 times, the HHI is (300/
953)2þ (100/953)2þ (3/953)2þ (50/953)2þ (500/953)2¼ 0.39.
Analyses
Because our data are hierarchically structured, multi-level
models are the appropriate statistical approach (Hox,1995; Leyland
& Groenewegen, 2003; Snijders & Bosker, 1999). In our case the
hierarchy is as follows: family physicians are nested within prac-
tices and patients are nested within family physicians.
As a dependent variable we used a measure of concentration,
the HHI. The concentration index is not a characteristic of a single
patient but of the aggregate of patients with the same diagnosis. It
is measured per diagnosis per physician. Therefore the level of the
patients is not relevant. The diagnoses per physician are pop-
ulations, consisting of patients, with certain characteristics,
including diagnosis, which are important in our analyses. These
populations are nested within family physicians and therefore
modeled as a level (see Web Appendix 2 for the full model, INSERT
LINK WEB SUPP FILE). The total variation in prescription is sepa-
rated into three parts: a part due to differences between pop-
ulations, a part due to differences between family physicians, and
a part due to differences between practices (Diez Roux, 2002;
Leyland & Groenewegen, 2003).
Since different family physicians have populations with the
same diagnoses the different HHIs are dependent between family
physicians. What family physicians can prescribe does also depend
on the diagnosis, and if they have populations with the same
diagnoses, it is more likely that theywill act the same. Thereforewe
produced a model, which allows for dependence between obser-
vations. The estimated means of the HHI will be presented.
To account for differences in patient population between family
physicians, we included the mean age and sex of the patient pop-
ulations of a family physician. Furthermore the number of patients
per diagnosis as well as the number of different drugs available per
Table 3















Male 85 85 92 78 73 74
Female 15 15 8 22 27 26
Age
<35 13 32 9 1 4 6
35–39 31 30 27 10 15 15
40–44 26 12 23 13 18 20
45–49 13 12 11 35 30 25
50–54 7 7 8 24 25 22
55–59 8 6 9 16 8 10
60þ 3 1 12 1 1 2
Type of practice
Solo 32 32 56 34 31 43
Shared 36 37 30 18 28 33
Group/Health centre 32 31 14 48 42 25
a Foets, van der Velden, & de Bakker, 1992.
b Schellevis, Westert, de Bakker, & Groenewegen, 2004.
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prescribed by all family physicians per diagnosis, the number of
months from 1987 until the guidelines were introduced, and the
number of family practitioners working in a practice were centered
around a meaningful value, so that the estimated HHI has an
interpretable meaning, and included in the model.Table 5
Differences between the HHI for the guideline and the reference group during
DNSGP1 and DNSGP2.
Description of the difference Difference p-value
A: DNSGP1 reference group and DNSGP2, reference group 9.1 <0.001
B: DNSGP1 guideline group and DNSGP2, guideline group 5.9 <0.001
C: DNSGP1 reference group and DNSGP1, guideline group 8.3 <0.001
D: DNSGP2 reference group and DNSGP2, guideline group 5.2 <0.001
E: DNSGP1 reference group, group practice and DNSGP1
reference group, single handed practice
4.5 ¼0.002
F: DNSGP1 guideline group, group practice and DNSGP1
guideline group, single handed practice
2.5 ¼0.06
G: DNSGP2 reference group, group practice and DNSGP2
reference group, single handed practice
2.6 ¼0.16
H: DNSGP2 guideline group, group practice and DNSGP2
guideline group, single handed practice
4.3 ¼0.01Testing hypotheses
The hypothesis that variation in prescription has decreased with
the introduction of guidelines was tested by comparing the differ-
ence in HHIs between the reference and the guideline group for
DNSGP1 and DNSGP2. If guidelines reduce variation:
 The HHI for the guideline groupwould have increased between
DNSGP1 and DNSGP2 while the HHI for the reference group
remained the same, increased less, or decreased (results are in
Table 5, A and B).
The hypothesis that variation in prescription for the guideline
group has decreased more for family physicians in single-handed
practices than for family physicians in group practices was tested
by examining differences between family physicians in single-
handed and group practices, for the guideline and reference group
separately. Besides it was tested if guidelines work differently for
family physicians in group practices and for family physicians in
single-handed practices:
 There would be a difference in HHI between single-handed
practices and group practices for both the guideline and the
reference group during DNSGP1. The HHI would be higher for
the group practices (results are in Table 5, E and F);
 There would be a difference in HHI between single-handed
practices and group practices for the reference group duringTable 4
Mean HHI for the reference and guideline group during DNSGP1 and DNSGP2.
Description of the group Mean HHI (standard error)
DNSGP1, reference group 82.7 (0.8)
DNSGP1, guideline group 74.3 (0.7)
DNSGP2, reference group 73.6 (1.0)
DNSGP2, guideline group 68.4 (0.9)DNSGP2. The HHI would be higher for the group practices
(results are in Table 5, G);
 The difference in HHI for the guideline group between DNSGP1
and DNSGP2 for single-handed practices would be large
compared to this difference for group practices (results are in
Table 5, L and K);
 The difference in HHI for the guideline group between DNSGP1
and DNSGP2 for single-handed practices would be large
compared to the difference for the reference group (results are
in Table 5, L and J);
 The difference in HHI for the guideline group between DNSGP1
and DNSGP2 for group practices would be comparable to the
difference for the reference group (results are in Table 5, K, I
and M).Results
A summary of hypotheses, tests, and results can be found in
Table 7.I: DNSGP1 reference group, group practice and DNSGP2
reference group, group practice
12.4 <0.001
J: DNSGP1 reference group, single handed practice and
DNSGP2 reference group, single handed practice
5.3 <0.001
K: DNSGP1 guideline group, group practice and DNSGP2
guideline group, group practice
9.2 <0.001
L: DNSGP1 guideline group, single-handed practice and
DNSGP2 guideline group, single-handed practice
2.4 ¼0.06
M: I and K 3.2 ¼0.13
Table 6
Mean HHI for the reference and guideline group, single-handed and group practices
during DNSGP1 and DNSGP2.
Description of the group Mean HHI (standard error)
DNSGP1 reference group, group practice 83.8 (1.0)
DNSGP1 reference group, single handed practice 79.3 (1.1)
DNSGP1 guideline group, group practice 75.1 (0.9)
DNSGP1 guideline group, single handed practice 72.5 (1.1)
DNSGP2 reference group, group practice 71.4 (1.4)
DNSGP2 reference group, single handed practice 73.9 (1.2)
DNSGP2 guideline group, group practice 65.8 (1.2)
DNSGP2 guideline group, single handed practice 70.1 (1.2)
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Tables 4 and 5 show that the HHI is higher during DNSGP1 than
during DNSGP2. More different drugs were prescribed per diag-
nosis during DNSGP2. This is true for both the guideline and the
reference group (Table 5, A and B). The difference in HHI between
the reference and the guideline group decreased, because the HHI
decreased more for the reference than for the guideline group
(Table 5, C, D). The number of different drugs prescribed per diag-
nosis increasedmore for the reference than for the guideline group.
The hypothesis that variation decreased after the introduction of
guidelines was not conﬁrmed. The results indicate that guidelines
did not reduce variation in drug prescription, but tempered the
increase of variation in prescription.Is there a difference between group and single-handed practices?
For all groups the HHI is higher during DNSGP1 than during
DNSGP2 (Table 6).
First the assumption was tested that group practices have local
standards. This implies that there is a difference in HHI between
single-handed practices and group practices for the guideline
group as well as for the reference group. Table 5 shows that there is
no difference for the guideline group (F), but there is a differenceTable 7
Description of hypotheses, testing and results.
General Hypothesis Assumption Test
Variation in prescription has decreased





Variation in prescription has decreased
more for family physicians working in
single-handed practices than for family





























is comparafor the reference group (E). In line with the assumption, the HHI is
higher for the group practices, indicating that less different drugs
are prescribed in group practices. Table 5 (G) shows that there is no
difference in HHI between family physicians in single-handed
practices and family physicians in group practices for the reference
group during DNSGP2.
The difference in HHI for the guideline group between DNSGP1
and DNSGP2 for single-handed practices was not found to be large
compared to this difference for group practices (Table 5, K and L).
Table5 (L and J) also shows that thedifference inHHI for theguideline
group between DNSGP1 and DNSGP2 for single-handed practices is
not large compared to thedifference for the referencegroup. Finally, it
was found that the difference for the guideline group between
DNSGP1 and DNSGP2 for group practices is comparable to the
difference for the reference group (Table 5, K, I and M).
The results in Table 5 (I,J,K,L) generally give indications of an
increase in the total number of drugs prescribed for the reference as
well as the guideline group, for both single-handed and group
practices. It also shows that the number of drugs increasedmore for
the reference group compared to the guideline group and that this
effect applies most to single-handed practices. Between DNSGP1
and DNSGP2 the difference between single-handed and group
practices reversed. During DNSGP1 there were less different drugs
prescribed in group practices, while during DNSGP2 therewere less
different drugs prescribed in single-handed practices. Based on
these results, we conclude that guidelines tempered the increase in
the number of different drugs prescribed primarily for family
physicians working in single-handed practices. The hypothesis that
variation in drug prescription has decreased more for family
physicians working in single-handed practices than for family
physicians working in group practices was not conﬁrmed.Discussion
Due to processes of global rationalization, more uniformity
occurs throughout the world. Since those rationalization processesResult in Table Test result in
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guidelines, more uniformity is to be expected.
We found in this study that although more different drugs are
prescribed during DNSGP2 for both the reference and the guideline
group, the change is higher for the reference group. The overall
increase in the number of different drugs prescribed can be
explained by the fact that there are far more different drugs
available during DNSGP2 than during DNSGP1. That the increase in
the number of different drugs prescribed is lower for the guideline
group indicates that guidelines temper the effect of the availability
of more drugs.
We found no signiﬁcant difference between the reference group
and the guideline group for family physicians in group practices
between DNSGP1 and DNSGP2. This suggests that guidelines did
not have an effect on the variation for family physicians in group
practices. In single-handed practices a signiﬁcant increase in vari-
ation was found for the reference group, while no signiﬁcant
increase was found for the guideline group. In group practices
a signiﬁcant increase in variation was found for both groups.
Therefore it was concluded that in line with the hypothesis,
guidelines primarily had an effect on variation in single-handed
practices.
The importance of reducing the number of different drugs
prescribed lies in the idea that family physicians become more
familiar with the drugs, which results in better quality for patients
and lower health care expenses (Denig, Haaijer-Ruskamp, &
Zijsking, 1988; Hill-Smith, 1996).
In this studywe testedwhethermore uniformity in prescription,
in other words less variation in drugs prescribed, is created after
the introduction of guidelines. In order to do so, we analyzed data
from two national medical record studies, one held before the
introduction of NHG-guidelines, and the other held after intro-
duction of those guidelines. Although this sounds straightforward,
it was complicated to analyze. Two developments go together in
the analysis.
First, the number of available drugs has increased by almost 10
percent in the period between 1995 and 2001 (Medicines Evalua-
tion Board 1999, 2005), which would imply an increase in the
variation in prescription. Moreover, the pharmaceutical industry
inﬂuences prescription by introducing more different drugs onto
the market, and patients might ask for certain drugs, resulting in
more different drugs prescribed during DNSGP2. This would lead to
less uniformity in prescribing.
Second, guidelines were introduced which would imply
a decrease in the variation in prescription. Guidelines themselves
could also be a cause of more variation in prescription for in some of
the guidelines it is recommended to start with one drug and then
follow it with another. All guidelines are not introduced at the same
time, but over a 15 year period. With respect to variation the effect
of the introduction of a guideline would be a certain amount of
variation at the beginning, more variation at a later stage when
more physicians are beginning to work according to the guideline,
and less variation when the introduction is completed and all
physicians are working according to the guidelines (Coleman et al.,
1966; Rogers, 2005). Variation is thus inﬂuenced by the stage at
which guidelines are introduced in this process. In order to control
for the different stage in which each guideline might be found, the
number of months since 1987 until the guidelines were introduced,
were included in the analyses. In spite of these complications
affecting the analysis, a measure had to be chosen that could be
used to compute variation in prescription.
One possibility would be to count the number, or range of
different drugs prescribed, but this measure is insensitive to the
number of times a drug is prescribed. For example, the range is two
if both drugs are each prescribed ten times, but also when one drugis prescribed ten times and the other is prescribed a hundred times.
Measures of concentration are sensitive to the number of times
a drug is prescribed. Therefore the Herﬁndahl-Hirschman Index
(HHI), which is a measure of concentration, was used; the higher
the HHI, the more concentrated the ‘market’, or the less different
drugs are often prescribed.
We conclude that the introduction of guidelines, although it
probably tempered the increase in variation, did not reduce vari-
ation. The introduction of guidelines alone is not enough to change
behavior and reduce variation. A step further is to intervene in
physicians’ daily routines, instead of using rules and regulations
(de Jong, Groenewegen, Spreeuwenberg, Westert, & de Bakker,
2009).Appendix. Supplementary data
Supplementary data associated with this article can be found in
the online version, at doi:10.1016/j.socscimed.2009.10.016.References
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